Paroxysmal AF Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Paroxysmal AF clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

Atrial Fibrillation (AF)Persistant Atrial FibrillationParoxysmal AF
Arga Medtech SA360 enrolled26 locationsNCT06784466
Recruiting
Not Applicable

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

Atrial FibrillationAtrial ArrhythmiaPersistent Atrial Fibrillation+1 more
Abbott Medical Devices300 enrolled22 locationsNCT07181590
Recruiting
Not Applicable

Feasibility Study of the FARAFLEX Mapping and PFA System

Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
Boston Scientific Corporation250 enrolled4 locationsNCT06510556
Recruiting
Not Applicable

Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)

Paroxysmal AF
Medtronic Cardiac Ablation Solutions300 enrolled9 locationsNCT07308847
Recruiting

FARAPULSE™ Pulsed Field Ablation System

Paroxysmal AF
Boston Scientific Corporation500 enrolled1 locationNCT06762717
Recruiting
Not Applicable

Durability of Pulmonary Vein Isolation Using a Variable-Loop Biphasic Pulsed Field Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation

Paroxysmal AF
Erasmus Medical Center20 enrolled1 locationNCT07236619
Recruiting
Not Applicable

Evaluation of the Impact of Pulsed Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation

Atrial Fibrillation (AF)Paroxysmal AF
VZW Cardiovascular Research Center Aalst105 enrolled1 locationNCT06647485